Dr. Richard Lord Vincent, MD

Dr. Vincent practices at Ear,nose And Throat Associates Of Southeastern Connecticut in Waterford, Connecticut.

Dr. Vincent's NPI, 1003172685, was assigned on April 8, 2012. Dr. Vincent graduated from University of Maryland School of Medicine in 2017. Dr. Vincent holds Maryland license 1003172685.

Dr. Vincent's primary practice is Ear,nose and Throat Associates of Southeastern Connecticut, at 201 Boston Post Rd, Waterford, CT 06385-2805. The practice phone is (860) 442-0407.

Dr. Vincent's primary practice is Ear,nose And Throat Associates Of Southeastern Connecticut in Waterford, Connecticut. Dr. Vincent is also affiliated with Lawrence + Memorial Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Vincent to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vincent practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Vincent's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Vincent is licensed in Maryland.

CMS data shows 1,623 Medicare services from Dr. Vincent across 8 procedure codes in 2024, for 411 Medicare patients. Medicare paid $72,174 for them. Every service was in an office.

CMS counts 411 Medicare patients who saw Dr. Vincent in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vincent's median patient age at 70, with 55% women.

In 2024, Dr. Vincent wrote 806 Medicare Part D claims for 304 patients. 88% of them were for generic drugs. CMS names the drug for 651 of them, across 19 drugs with 11 or more claims each, at $61,216 in total drug cost. In 2023, CMS named 547 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Vincent for performance year 2024, reported as part of a group. Dr. Vincent accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Vincent, published from 2012 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Ultraviolet Rays, Disinfection and Air Microbiology. Dr. Vincent has published most often in Build Environ. Dr. Vincent's most frequent co-authors are Edward A. Nardell, MD, David M. Rapoport, MD and Jacob Scott Wolf, DO.

CMS Open Payments shows 39 general payments to Dr. Vincent from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $661.

Dr. Vincent graduated from University of Maryland School of Medicine in 2017.